Seeking Alpha

EPIRUS Biopharmaceuticals, Inc (EPRS)

  • SA Editor Mike Taylor | Send Message 13 Feb
      • Brendan O'Boyle | Send Message 5 Feb

        An Update On Epirus In Light Of Recent Developments $EPRS
          • Brendan O'Boyle | Send Message 8 Jan

            $EPRS up 37% today.
            Reply (4)
          • View all 4 replies
            • Brendan O'Boyle | Send Message 9 Jan
              : Holding gains, increased visibility for US biosimilars is the catalyst. However, a number of other small biotechs surged yesterday as well.
            • Brendan O'Boyle | Send Message 9 Jan
              : Long-term this is an interesting play, although as a trade it wouldn't surprise me to see some profit taking:
              • Brendan O'Boyle | Send Message 31 Dec 2014

                Epirus Biopharma: A High Risk/High Reward Biosimilar Investment $EPRS
                  • RobertJames | Send Message 18 Jun 2014

                    Wednesdays Watch FuelCell Energy $FCEL - Zalicus $EPRS - Viscount Systems $VSYS May add
                      • freefdawatchlist | Send Message 12 Jun 2014

               Premarket Trading Ideas for Jun 13: $ARTX, $EPRS, $FNSR, $CLDX, $EXPR, $IMGN, $XOMA, $ACHN, $UVXY, $XIV,
                          • Tater13 | Send Message 11 Jun 2014

                            $EPRS Whats going on with ZLCS
                              • pat45 | Send Message 11 Jun 2014

                                $EPRS up on partners results, but won't that reduce amount of stock zlcs will get at merger? partner is just buying zlcs to go public imo
                                  • ‫خالد حمد‬‎ | Send Message 19 Apr 2014
                                      • Penny Stock Pinnacle | Send Message 16 Apr 2014

                                        Expect pullback on $EPRS, but keep an eye out, I also expect a possible push later on, still opportunities to make money IMO.
                                          Visit Seeking Alpha's
                                          EPRS vs. ETF Alternatives
                                          Company Description
                                          Epirus Biopharmaceuticals Inc is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diorders.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States